Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma : An overview of 6,633 patients from 27 randomized trials

Volltext

Prognostic features of asymptomatic multiple myeloma von Weber, Donna M., Dimopoulos, Meletios A., Moulopoulos, Lia A., Delasalle, Kay B., Smith, Terry, Alexanian, Raymond

Volltext

Prognostic significance of magnetic resonance imaging in patients with asymptomatic multiple myeloma von MOULOPOULOS, L. A, DIMOPOULOS, M. A, SMITH, T. L, WEBER, D. M, DELASALLE, K. B, LIBSHITZ, H. I, ALEXANION, R

Volltext

Risk of disease progression in asymptomatic multiple myeloma von Dimopoulos, Meletios A., Moulopoulos, Angela, Smith, Terry, Delasalle, Kay B., Alexanian, Raymond

Volltext

Thiotepa, Busulfan, and Cyclophosphamide: A New Preparative Regimen for Autologous Marrow or Blood Stem Cell Transplantation in High-Risk Multiple Myeloma von Dimopoulos, Meletios A., Alexanian, Raymond, Przepiorka, Donna, Hester, Jeane, Andersson, Borje, Giralt, Sergio, Mehra, Rakesh, Besien, Koen van, Delasalle, Kay B., Reading, Christopher, Deisseroth, Albert B., Champlin, Richard E.

Volltext

Treatment of Waldenstrom's macroglobulinemia resistant to standard therapy with 2-chlorodeoxyadenosine: Identification of prognostic factors von Dimopoulos, M. A., Weber, D., Delasalle, K. B., Keating, M., Alexanian, R.

Volltext

A028 Superior Outcomes with Recent Treatments for Myeloma von Delasalle, KB, Wang, M, Thomas, S, Giralt, S, Alexanian, R

Volltext

A035 Predictive Features for Long Survival in Multiple Myeloma von Wang, M, Delasalle, KB, Thomas, S, Giralt, S, Alexanian, R

Volltext

Combination therapy with interferon‐dexamethasone for newly diagnosed patients with multiple myeloma von Dimopoulos, Meletios A., Weber, Donna, Delasalle, Kay B., Alexanian, Raymond

Volltext

Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. Myeloma Trialists' Collaborati... von Pasquali, S, Maqueo, JD, Vela, J, Kyle, RA, Leong, T, Fritz, E, Suciu, S, Palva, IP, Oivanen, T, Corrado, C, Lastiri, FJ, Peest, D, Kildahl-Andersen, O, Maniatis, A, Alison, R, Clarke, M, Evans, V, Gray, R, Greaves, E, Hall, E, Hicks, C, James, S, Peto, R, Richards, S, Sinclair, D, Tooth, A, Wheatley, K, Avvisati, G, Boccadoro, M, Bugliosi, R, Mandelli, F, Petrucci, MT, Pileri, A, Tribalto, M, Alexanian, R, Delasalle, KB, Child, J, Dunn, J, MacLennan, I, Milligan, D, Mellstedt, H, Osterborg, A, Hjorth, M, Holmberg, E, Rodjer, S, Westin, J, Kamiya, O, Shimizu, K, Bergsagel, DE, Shustik, C, Hippe, E, Kjaersgaard, E, Turesson, I, Riccardi, A, Ucci, G, Blade, J, Fontanillas, M, De Rosa, L, Montuoro, A, Bartolucci, AA, Omura, GA, Stagg, M, Salmon, S, Tangen, C, Jacobs, P, Wood, L, Levy, LM

Volltext

Thiotepa, busulfan, and cyclophosphamide: a new preparative regimen for autologous marrow or blood stem cell transplantation in high-risk multiple myeloma von Dimopoulos, MA, Alexanian, R, Przepiorka, D, Hester, J, Andersson, B, Giralt, S, Mehra, R, van Besien, K, Delasalle, KB, Reading, C

Volltext